Patents by Inventor Shuanghu Liu

Shuanghu Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240116944
    Abstract: The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections (e.g., Zika virus, dengue virus, Powassan virus, Chikungunya virus, Enterovirus, respiratory syntactical virus (RSV), Rift Valley fever, Influenza virus, Tacaribe virus, Mayaro virus, West Nile virus, yellow fever virus, and coronavirus), and disorders of uncontrolled cellular proliferation (e.g., cancer). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: November 10, 2023
    Publication date: April 11, 2024
    Inventors: Darrell Davis, Shuanghu Liu
  • Patent number: 11946453
    Abstract: A damping device and a wind turbine generator system comprising the damping device. The damping device comprises: damping components; structural supports, the structural supports connecting the damping components to a mass block provided on an object to be damped, each structural support comprising a gear, and the gear being rotatably provided on the structural support; and guide rails, wherein each guide rail has a predetermined curvature, each guide rail has a first end used for being rotatably connected to the object to be damped and a second end supported on the corresponding structural support, a tooth portion engaged with a gear is formed on a side portion of each guide rail, and when the mass block swings, the swing of the mass block is converted into transmission by means of the engagement transmission between the guide rail and the gear for input into the corresponding damping component.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: April 2, 2024
    Assignee: BEIJING GOLDWIND SCIENCE & CREATION WINDPOWER EQUIPMENT CO., LTD.
    Inventors: Yan Liu, Liang Bai, Shuanghu Li, Jiankun Chu, Wensi Ren
  • Publication number: 20220275001
    Abstract: The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections (e.g., Zika virus, dengue virus, Powassan virus, Chikungunya virus, Enterovirus, respiratory syntactical virus (RSV), Rift Valley fever, Influenza virus, Tacaribe virus, Mayaro virus, West Nile virus, yellow fever virus, and coronavirus), and disorders of uncontrolled cellular proliferation (e.g., cancer). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: April 28, 2022
    Publication date: September 1, 2022
    Inventors: Darrell Davis, Shuanghu Liu
  • Patent number: 11339173
    Abstract: The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections (e.g., Zika virus, dengue virus, Powassan virus, Chikungunya virus, Enterovirus, respiratory syntactical virus (RSV), Rift Valley fever, Influenza virus, Tacaribe virus, Mayaro virus, West Nile virus, yellow fever virus, and coronavirus), and disorders of uncontrolled cellular proliferation (e.g., cancer). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: May 24, 2022
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Darrell Davis, Shuanghu Liu
  • Publication number: 20210079008
    Abstract: The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections (e.g., Zika virus, dengue virus, Powassan virus, Chikungunya virus, Enterovirus, respiratory syntactical virus (RSV), Rift Valley fever, Influenza virus, Tacaribe virus, Mayaro virus, West Nile virus, yellow fever virus, and coronavirus), and disorders of uncontrolled cellular proliferation (e.g., cancer). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: September 16, 2020
    Publication date: March 18, 2021
    Inventors: Darrell Davis, Shuanghu Liu